Background: A 1H-NMR-derived metabolomic index based on early umbilical cord blood alterations of succinate, glycerol, 3-hydroxybutyrate and O-phosphocholine has shown potential for the prediction of hypoxic-ischaemic encephalopathy (HIE) severity. Objective: To evaluate whether this metabolite score can predict 3-year neurodevelopmental outcome in infants with perinatal asphyxia and HIE, compared with current standard biochemical and clinical markers. Methods: From September 2009 to June 2011, infants at risk of perinatal asphyxia were recruited from a single maternity hospital. Cord blood was drawn and biobanked at delivery. Neonates were monitored for development of encephalopathy both clinically and electrographically. Neurodevelopmental outcome was assessed at 36-42 months using the Bayley Scales of Infant and Toddler Development, ed. III (BSID-III). Death and cerebral palsy were also considered as abnormal end points. Results: Thirty-one infants had both metabolomic analysis and neurodevelopmental outcome at 36-42 months. No child had a severely abnormal BSID-III result. The metabolite index significantly correlated with outcome (ρ2 = 0.30, p < 0.01), which is robust to predict both severe outcome (area under the receiver operating characteristic curve: 0.92, p < 0.01) and intact survival (0.80, p = 0.01). There was no correlation between the index score and performance in the individual BSID-III subscales (cognitive, language, motor). Conclusions: The metabolite index outperformed other standard biochemical markers at birth for prediction of outcome at 3 years, but was not superior to EEG or the Sarnat score.

Keywords:
Metabolomics, Hypoxic-ischaemic encephalopathy, Perinatal asphyxia, Neurodevelopmental outcome
1.
Lee AC, Kozuki N, Blencowe H, Vos T, Bahalim A, Darmstadt GL, Niermeyer S, Ellis M, Robertson NJ, Cousens S, Lawn JE: Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res 2013;74(suppl 1):50-72.
2.
Murray DM, Ryan CA, Boylan GB, Fitzgerald AP, Connolly S: Prediction of seizures in asphyxiated neonates: correlation with continuous video-electroencephalographic monitoring. Pediatrics 2006;118:41-46.
3.
Ugwumadu A: Are we (mis)guided by current guidelines on intrapartum fetal heart rate monitoring? Case for a more physiological approach to interpretation. Br J Obstet Gynaecol 2014;121:1063-1070.
4.
Ugwumadu A: Understanding cardiotocographic patterns associated with intrapartum fetal hypoxia and neurologic injury. Best Pract Res Clin Obstet Gynaecol 2013;27:509-536.
5.
Nelson KB, Dambrosia JM, Ting TY, Grether JK: Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med 1996;334:613-618.
6.
Ruth VJ, Raivio KO: Perinatal brain damage: predictive value of metabolic acidosis and the Apgar score. BMJ 1988;297:24-27.
7.
Natarajan G, Shankaran S, Laptook AR, Pappas A, Bann CM, McDonald SA, Das A, Higgins RD, Hintz SR, Vohr BR: Apgar scores at 10 min and outcomes at 6-7 years following hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2013;98:F473-F479.
8.
Murray DM, Boylan GB, Fitzgerald AP, Ryan CA, Murphy BP, Connolly S: Persistent lactic acidosis in neonatal hypoxic-ischaemic encephalopathy correlates with EEG grade and electrographic seizure burden. Arch Dis Child Fetal Neonatal Ed 2008;93:F183-F186.
9.
DuPont TL, Chalak LF, Morriss MC, Burchfield PJ, Christie L, Sanchez PJ: Short-term outcomes of newborns with perinatal acidemia who are not eligible for systemic hypothermia therapy. J Pediatr 2013;162:35-41.
10.
Horn AR, Swingler GH, Myer L, Linley LL, Chandrasekaran M, Robertson NJ: Early clinical predictors of a severely abnormal amplitude-integrated electroencephalogram at 48 h in cooled neonates. Acta Paediatr 2013;102: e378-e384.
11.
Horn AR, Swingler GH, Myer L, Linley LL, Raban MS, Joolay Y, Harrison MC, Chandrasekaran M, Rhoda NR, Robertson NJ: Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 h. BMC Pediatr 2013;13:52.
12.
Walsh BH, Murray DM, Boylan GB: The use of conventional EEG for the assessment of hypoxic ischaemic encephalopathy in the newborn: a review. Clin Neurophysiol 2011;122:1284-1294.
13.
Fanos V, Atzori L, Makarenko K, Melis GB, Ferrazzi E: Metabolomics application in maternal-fetal medicine. Biomed Res Int 2013;2013:720514.
14.
Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL: Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011;40:387-426.
15.
Denihan NM, Boylan GB, Murray DM: Metabolomic profiling in perinatal asphyxia: a promising new field. Biomed Res Int 2015;2015:9.
16.
Reinke SN, Walsh BH, Boylan GB, Sykes BD, Kenny LC, Murray DM, Broadhurst DI: 1H NMR derived metabolomic profile of neonatal asphyxia in umbilical cord serum: implications for hypoxic ischemic encephalopathy. J Proteome Res 2013;12:4230-4239.
17.
Pressler RM, Boylan GB, Morton M, Binnie CD, Rennie JM: Early serial EEG in hypoxic ischaemic encephalopathy. Clin Neurophysiol 2001;112:31-37.
18.
Murray DM, Boylan GB, Ryan CA, Connolly S: Early EEG findings in hypoxic-ischemic encephalopathy predict outcomes at 2 years. Pediatrics 2009;124:e459-e467.
19.
Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter E, Thoresen M, Whitelaw A, Brocklehurst P: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009;361:1349-1358.
20.
Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005;365:663-670.
21.
O'Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ: Interobserver variability of the 5-min Apgar score. J Pediatr 2006;149:486-489.
22.
Solberg R, Enot D, Deigner HP, Koal T, Scholl-Burgi S, Saugstad OD, Keller M: Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 2010;5:e9606.
23.
Liu J, Sheldon RA, Segal MR, Kelly MJ, Pelton JG, Ferriero DM, James TL, Litt L: 1H nuclear magnetic resonance brain metabolomics in neonatal mice after hypoxia-ischemia distinguished normothermic recovery from mild hypothermia recoveries. Pediatr Res 2013;74:170-179.
24.
Farooqui AA, Horrocks LA, Farooqui T: Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 2000;106:1-29.
25.
Prins ML: Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 2008;28:1-16.
26.
Marlow N: Measuring neurodevelopmental outcome in neonatal trials: a continuing and increasing challenge. Arch Dis Child Fetal Neonatal Ed 2013;98:F554-F558.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.